Isolation and characterization of purine-nucleoside phosphorylase-deficient T-lymphoma cells and secondary mutants with altered ribonucleotide reductase: Genetic model for immunodeficiency disease
AUTOR(ES)
Ullman, Buddy
RESUMO
The inherited deficiency of purine-nucleoside phosphorylase (PNPase; purine-nucleoside:orthophosphate ribosyltransferase, EC 2.4.2.1) in humans is associated with a severe deficiency of the T lymphocytes of the immune system. Because of the unsatisfactory nature of previously described model systems, we have selected, cloned, and characterized a mutant mouse T cell lymphoma (S49) completely deficient in PNPase. Of the four substrates of PNPase, only deoxyguanosine at low concentrations is toxic to the PNPase-deficient (NSU-1) cells.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=383191Documentos Relacionados
- Polynucleotide Phosphorylase-Deficient Mutants of Pseudomonas putida
- LOW LEUKOCYTE PHOSPHORYLASE IN HEPATIC PHOSPHORYLASE-DEFICIENT GLYCOGEN STORAGE DISEASE
- Cloning of human purine-nucleoside phosphorylase cDNA sequences by complementation in Escherichia coli.
- Cloning of human purine-nucleoside phosphorylase cDNA sequences by complementation in Escherichia coli
- Residual nitrobenzylthioinosine-resistant nucleoside transport in a transport mutant (AE1) of S49 murine T-lymphoma cells.